United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018

United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018

Summary

Global Markets Direct’s new report, ”United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018” provides key market data on the United Arab Emirates In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the United Arab Emirates In Vitro Diagnosticsmarket.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Beckman Coulter, Inc., Abbott Laboratories, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the United Arab Emirates In Vitro Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 12
2.1 What is This Report About? 12
3 In Vitro Diagnostics In United Arab Emirates 13
3.1 In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Constant, 2004-2018 13
3.2 In Vitro Diagnostics, United Arab Emirates, Company Share (2010-2011) 19
4 Clinical Chemistry In United Arab Emirates 21
4.1 Clinical Chemistry Overall Revenue, (2004-2018) 21
4.1.1 Clinical Chemisty Analyzers, Revenue (2004-2018) 25
4.1.2 Urine Analysis, Revenue (2004-2018) 29
4.2 Clinical Chemistry Distribution Share (2010-2011) 33
4.3 Clinical Chemistry, United Arab Emirates, Company Share (2010-2011) 34
5 Genetic Testing In United Arab Emirates 36
5.1 Genetic Testing Overall Revenue, (2004-2018) 36
5.2 Genetic Testing Distribution Share (2010-2011) 40
5.3 Genetic Testing, United Arab Emirates, Company Share (2010-2011) 41
6 Haematology In United Arab Emirates 43
6.1 Haematology Overall Revenue, (2004-2018) 43
6.1.1 Haematology Reagents, Revenue, (2004-2018) 47
6.1.2 Immunohaematology, Revenue (2004-2018) 51
6.1.3 Haemostasis, Revenue (2004-2018) 55
6.1.4 Haematology Rapid Tests, Revenue (2004-2018) 59
6.1.5 Haematology Cell Counters, Revenue (2004-2018) 63
6.2 Haematology Distribution Share (2010-2011) 67
6.3 Haematology, United Arab Emirates, Company Share (2010-2011) 68
7 Histology And Cytology In United Arab Emirates 70
7.1 Histology And Cytology Overall Revenue, (2004-2018) 70
7.2 Histology And Cytology Distribution Share (2010-2011) 74
7.3 Histology And Cytology, United Arab Emirates, Company Share (2010-2011) 75
8 Immuno Chemistry In United Arab Emirates 77
8.1 Immuno Chemistry Overall Revenue, (2004-2018) 77
8.1.1 Disease Specific Immunochemistry, Revenue (2004-2018) 81
8.1.2 Drugs of Abuse / Toxicology, Revenue (2004-2018) 85
8.1.3 Endocrinology Tests, Revenue (2004-2018) 88
8.1.4 Immunochemistry Rapid Tests, Revenue (2004-2018) 92
8.1.5 Therapeutic Drug Monitoring, Revenue (2004-2018) 96
8.1.6 Immunochemistry Analyzers, Revenue (2004-2018) 100
8.2 Immuno Chemistry Distribution Share (2010-2011) 104
8.3 Immuno Chemistry, United Arab Emirates, Company Share (2010-2011) 105
9 Infectious Immunology In United Arab Emirates 107
9.1 Infectious Immunology Overall Revenue, (2004-2018) 107
9.1.1 Infectious Immunology Rapid Tests, Revenue (2004-2018) 111
9.2 Infectious Immunology Distribution Share (2010-2011) 115
9.3 Infectious Immunology, United Arab Emirates, Company Share (2010-2011) 116
10 Microbiology Culture In United Arab Emirates 118
10.1 Microbiology Culture Overall Revenue, (2004-2018) 118
10.1.1 Microbiology Analyzers, Revenue (2004-2018) 122
10.2 Microbiology Culture Distribution Share (2010-2011) 126
10.3 Microbiology Culture, United Arab Emirates, Company Share (2010-2011) 127
11 Overview of Key Companies in United Arab Emirates In Vitro Diagnostics Market 129
11.1 F. Hoffmann-La Roche Ltd. 129
11.1.1 Company Overview 129
11.2 Siemens Healthcare 129
11.2.1 Company Overview 129
11.3 Beckman Coulter, Inc. 130
11.3.1 Company Overview 130
11.4 Abbott Laboratories 130
11.4.1 Company Overview 130
11.5 Ortho-Clinical Diagnostics Inc. 131
11.5.1 Company Overview 131
11.6 bioMerieux S.A. 131
11.6.1 Company Overview 131
11.7 ELITech Group 132
11.7.1 Company Overview 132
11.8 Becton, Dickinson and Company 132
11.8.1 Company Overview 132
11.9 Alere Inc. 133
11.9.1 Company Overview 133
11.10 Mindray Medical International Limited 133
11.10.1 Company Overview 133
11.11 Bio-Rad Laboratories, Inc. 134
11.11.1 Company Overview 134
11.12 PerkinElmer, Inc. 134
11.12.1 Company Overview 134
11.13 Sysmex Corporation 135
11.13.1 Company Overview 135
11.14 Thermo Fisher Scientific Inc. 135
11.14.1 Company Overview 135
11.15 Horiba, Ltd. 136
11.15.1 Company Overview 136
11.16 Grifols, S.A. 136
11.16.1 Company Overview 136
11.17 DiaSorin S.p.A 137
11.17.1 Company Overview 137
11.18 Qiagen N.V. 137
11.18.1 Company Overview 137
11.19 Gen-Probe Incorporated 138
11.19.1 Company Overview 138
11.20 Diagnostica Stago, Inc. 138
11.20.1 Company Overview 138
11.21 Life Technologies Corporation 139
11.21.1 Company Overview 139
11.22 Hologic, Inc. 139
11.22.1 Company Overview 139
11.23 Immucor, Inc. 140
11.23.1 Company Overview 140
11.24 Chembio Diagnostics, Inc. 140
11.24.1 Company Overview 140
11.25 Phadia AB 140
11.25.1 Company Overview 140
12 Appendix 141
12.1 Global Markets Direct Research Methodology 141
12.2 Definitions of Markets Covered in the Report 142
12.2.1 In Vitro Diagnostics 142
12.3 Secondary Research 153
12.4 Primary Research 153
12.5 Models 154
12.6 Forecasts 154
12.7 Expert Panel Validation 154
12.8 Currency Conversion 155
12.9 Contact Us 155
12.10 Disclaimer 155

1.1 List of Tables
Table 1: In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Constant, 2004-2018 14
Table 2: In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Constant, Historic, 2004-2011 16
Table 3: In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 18
Table 4: In Vitro Diagnostics, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011 20
Table 5: Clinical Chemistry, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 22
Table 6: Clinical Chemistry, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 24
Table 7: Clinical Chemisty Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 26
Table 8: Clinical Chemisty Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 28
Table 9: Urine Analysis, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 30
Table 10: Urine Analysis, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 32
Table 11: Clinical Chemistry, United Arab Emirates, Distribution Share by Revenue ($m), USD Constant, 2010-2011 33
Table 12: Clinical Chemistry, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011 35
Table 13: Genetic Testing, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 37
Table 14: Genetic Testing, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 39
Table 15: Genetic Testing, United Arab Emirates, Distribution Share by Revenue ($m), USD Constant, 2010-2011 40
Table 16: Genetic Testing, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011 42
Table 17: Haematology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 44
Table 18: Haematology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 46
Table 19: Haematology Reagents, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 48
Table 20: Haematology Reagents, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 50
Table 21: Immunohaematology, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 52
Table 22: Immunohaematology, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 54
Table 23: Haemostasis, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 56
Table 24: Haemostasis, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 58
Table 25: Haematology Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 60
Table 26: Haematology Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 62
Table 27: Haematology Cell Counters, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 64
Table 28: Haematology Cell Counters, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 66
Table 29: Haematology, United Arab Emirates, Distribution Share by Revenue ($m), USD Constant, 2010-2011 67
Table 30: Haematology, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011 69
Table 31: Histology And Cytology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 71
Table 32: Histology And Cytology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 73
Table 33: Histology And Cytology, United Arab Emirates, Distribution Share by Revenue ($m), USD Constant, 2010-2011 74
Table 34: Histology And Cytology, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011 76
Table 35: Immuno Chemistry, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 78
Table 36: Immuno Chemistry, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 80
Table 37: Disease Specific Immunochemistry, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 82
Table 38: Disease Specific Immunochemistry, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 84
Table 39: Drugs of Abuse / Toxicology, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 86
Table 40: Drugs of Abuse / Toxicology, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 87
Table 41: Endocrinology Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 89
Table 42: Endocrinology Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 91
Table 43: Immunochemistry Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 93
Table 44: Immunochemistry Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 95
Table 45: Therapeutic Drug Monitoring, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 97
Table 46: Therapeutic Drug Monitoring, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 99
Table 47: Immunochemistry Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 101
Table 48: Immunochemistry Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 103
Table 49: Immuno Chemistry, United Arab Emirates, Distribution Share by Revenue ($m), USD Constant, 2010-2011 104
Table 50: Immuno Chemistry, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011 106
Table 51: Infectious Immunology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 108
Table 52: Infectious Immunology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 110
Table 53: Infectious Immunology Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 112
Table 54: Infectious Immunology Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 114
Table 55: Infectious Immunology, United Arab Emirates, Distribution Share by Revenue ($m), USD Constant, 2010-2011 115
Table 56: Infectious Immunology, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011 117
Table 57: Microbiology Culture, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 119
Table 58: Microbiology Culture, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 121
Table 59: Microbiology Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 123
Table 60: Microbiology Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 125
Table 61: Microbiology Culture, United Arab Emirates, Distribution Share by Revenue ($m), USD Constant, 2010-2011 126
Table 62: Microbiology Culture, United Arab Emirates, Company Share by Revenue ($m), USD Constant, 2010-2011 128

1.2 List of Figures
Figure 1: In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Constant, 2004-2018 13
Figure 2: In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Constant, Historic, 2004-2011 15
Figure 3: In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 17
Figure 4: In Vitro Diagnostics, United Arab Emirates, Company Share (%), 2011 19
Figure 5: Clinical Chemistry, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 21
Figure 6: Clinical Chemistry, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 23
Figure 7: Clinical Chemisty Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 25
Figure 8: Clinical Chemisty Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 27
Figure 9: Urine Analysis, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 29
Figure 10: Urine Analysis, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 31
Figure 11: Clinical Chemistry, United Arab Emirates, Company Share (%), 2011 34
Figure 12: Genetic Testing, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 36
Figure 13: Genetic Testing, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 38
Figure 14: Genetic Testing, United Arab Emirates, Company Share (%), 2011 41
Figure 15: Haematology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 43
Figure 16: Haematology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 45
Figure 17: Haematology Reagents, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 47
Figure 18: Haematology Reagents, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 49
Figure 19: Immunohaematology, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 51
Figure 20: Immunohaematology, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 53
Figure 21: Haemostasis, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 55
Figure 22: Haemostasis, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 57
Figure 23: Haematology Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 59
Figure 24: Haematology Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 61
Figure 25: Haematology Cell Counters, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 63
Figure 26: Haematology Cell Counters, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 65
Figure 27: Haematology, United Arab Emirates, Company Share (%), 2011 68
Figure 28: Histology And Cytology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 70
Figure 29: Histology And Cytology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 72
Figure 30: Histology And Cytology, United Arab Emirates, Company Share (%), 2011 75
Figure 31: Immuno Chemistry, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 77
Figure 32: Immuno Chemistry, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 79
Figure 33: Disease Specific Immunochemistry, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 81
Figure 34: Disease Specific Immunochemistry, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 83
Figure 35: Drugs of Abuse / Toxicology, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 85
Figure 36: Drugs of Abuse / Toxicology, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 87
Figure 37: Endocrinology Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 88
Figure 38: Endocrinology Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 90
Figure 39: Immunochemistry Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 92
Figure 40: Immunochemistry Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 94
Figure 41: Therapeutic Drug Monitoring, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 96
Figure 42: Therapeutic Drug Monitoring, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 98
Figure 43: Immunochemistry Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 100
Figure 44: Immunochemistry Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 102
Figure 45: Immuno Chemistry, United Arab Emirates, Company Share (%), 2011 105
Figure 46: Infectious Immunology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 107
Figure 47: Infectious Immunology, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 109
Figure 48: Infectious Immunology Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 111
Figure 49: Infectious Immunology Rapid Tests, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 113
Figure 50: Infectious Immunology, United Arab Emirates, Company Share (%), 2011 116
Figure 51: Microbiology Culture, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 118
Figure 52: Microbiology Culture, United Arab Emirates, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 120
Figure 53: Microbiology Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 122
Figure 54: Microbiology Analyzers, United Arab Emirates, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 124
Figure 55: Microbiology Culture, United Arab Emirates, Company Share (%), 2011 127
Figure 56: Global Markets Direct Methodology 141